Loxapine Succinate is the succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent with antiemetic, sedative, anticholinergic, and antiadrenergic actions. Loxapine succinate exerts its actions by blocking the dopamine receptors at postsynaptic receptor sites in the limbic system, cortical system and basal ganglia, thereby reducing the hallucinations and delusions that are associated with schizophrenia. This agent also exerts extrapyramidal side effects. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Loxapac, Cloxazepin and Daxolin. Its PubChem CID is 71399.
Loxapine succinate
| CAS No | 27833-64-3 |
|---|---|
| Molecular Formula | C22H24ClN3O5 |
| Molecular Weight | 445.90 g/mol |
| Synonyms | butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Loxapine Succinate is the succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent with antiemetic, sedative, anticholinergic, and antiadrenergic actions.
The listed CAS number is 27833-64-3.
The listed molecular formula is C22H24ClN3O5.
The listed molecular weight is 445.90 g/mol.
butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine.
The source lists Loxapac, Cloxazepin and Daxolin.